guanylyl-imidodiphosphate has been researched along with Glaucoma* in 1 studies
1 other study(ies) available for guanylyl-imidodiphosphate and Glaucoma
Article | Year |
---|---|
Ocular alpha 2-receptor subclasses and antiglaucoma efficacy.
An overview of the ocular hypotensive actions of some alpha 2-agonists with imidazoline structures is presented. These agents inhibit isoproterenol-stimulated adenylate cyclase (AC) activity in ciliary process membrane through a Na+ and GTP-dependent mechanism. Receptor binding studies with the alpha 2-agonist radioligand [125I] p-iodoclonidine ([125I]PIC) in rabbit ciliary body membranes indicate that the alpha 2-receptor subtype is alpha 2A. Gpp(NH)p and NaCl dose-dependently decreased the number of [125I]PIC binding sites by shifting the receptor-G protein complexes from the high affinity state to the low affinity state for agonist binding. This is consistent with the observations that inhibition of AC was Na+ and GTP dependent. The NaCl and Gpp(NH)p effects on binding appeared to be through different mechanisms. The alpha 2-receptor in ciliary process thus appears to be an alpha 2A-receptor that is negatively coupled to the AC-cAMP generating system. Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Animals; Ciliary Body; Dose-Response Relationship, Drug; Female; Glaucoma; Guanylyl Imidodiphosphate; Imidazoles; Intraocular Pressure; Male; Rabbits; Receptors, Adrenergic, alpha-2; Sodium Chloride | 1994 |